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Abstract
Chlamydia trachomatis (Ct) is an obligate intracellular human pathogen that multiplies within a parasitophorous vacuole
called an inclusion. We report that the location of several host-cell proteins present in the cytosol, the nucleus, and
membranes was altered during Ct development. The acyl-CoA synthetase enzyme ACSL3 and the soluble acyl-CoA binding
protein ACBD6 were mobilized from organelle membranes and the nucleus, respectively, into the lumen of the inclusion.
The nuclear protein ZNF23, a pro-apoptosis factor, was also translocated into the inclusion lumen. ZNF23, among other
proteins, might be targeted by Ct to inhibit host cell apoptosis, thereby enabling bacterial survival. In contrast, the acyl-
CoA:lysophosphatidylcholine acyltransferase LPCAT1, an endoplasmic reticulum membrane protein, was recruited to the
inclusion membrane. The coordinated action of ACBD6, ACSL3 and LPCAT1 likely supports remodeling and scavenging of
host lipids into bacterial-specific moieties essential to Ct growth. To our knowledge, these are the first identified host
proteins known to be intercepted and translocated into the inclusion.
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Introduction
Chlamydia trachomatis (Ct) is a bacterium that is responsible for the
majority of sexually transmitted diseases and preventable ocular
blindness in the world today [1]. Upon entry into the host cell, Ct
undergoes rapid transformation from a metabolically dormant
infectious particle, the elementary body (EB), to a replicative non-
infectious form called the reticulate body (RB). Early during intra-
cellular development, the RBs multiply by binary fission protected
inside a newly formed parasitophorous vacuole called an inclusion
[2–5]. This obligate intracellular organism has a small genome
(1.05 Mb) with about a thousand predicted ORFs [6–8].
Confined in the inclusion, the bacteria intercept nutrients and
metabolites of the host cell. Several bacterial produced systems,
such as ABC transporters and a type III secretion system, are
essential to the survival of the pathogen [5,9–11]. In particular,
host-derived lipids, including ceramide and sphingomyelin, are
scavenged to sustain the expansion of the membrane surrounding
the inclusion and the membranes of the multiplying bacteria
[5,12–21]. The RBs lack de novo synthesis for some glyceropho-
spholipids, such as phosphatidylcholine (PC). Although PC is
exclusively synthesized in the endoplasmic reticulum (ER)
membrane of the host cells, it is the second most abundant lipid
present in both EB and RB membranes and accounts for 40% of
total bacterial lipids [22].
The PC molecular species composition of the inclusion
membrane is similar to the membrane of the host cells but not
of the EB and RB membranes, which contain PC species unique to
the organism. Bacterial PC is characterized by the presence of
branched-fatty acids at the sn-2 position that do not exist in
eukaryotic lipids and host membranes [22]. Thus, host PC
molecules are intercepted and modified to new species before their
incorporation into the bacterial membranes. These findings
indicate that a de-acylation/re-acylation cycle of host PC
molecules into bacterial PC species is occurring, and is probably
taking place at the membrane of the inclusion (reviewed in [5]).
This remodeling cycle, also know as the Lands’ pathway, is
essential for maintaining the composition of eukaryotic mem-
branes [23]. For an intracellular organism requiring host lipids for
its survival, the host Lands’ pathway enzymes provide an alternate
mechanism to generate specific bacterial lipid species.
We report that long-chain acyl-CoA synthetase, ACSL3, a
membrane-bound protein of the mitochondria and Golgi appa-
ratus [24], was recruited into the lumen of the Ct inclusions in
human cells. ACSL3 activates long-chain fatty acids, present at the
sn-2 position of lipids, by catalyzing the ATP-dependent
esterification to acyl-CoAs [25], In addition, an acyl-CoA binding
protein, ACBD6, with high specificity for long-chain acyl-CoAs
species abundant at the sn-2 [26], was also detected inside the
inclusion. ACBD6 rapidly disappeared from the nucleus of
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e36843infected cells as did the nuclear zinc finger protein, ZNF23, and
both were localized solely in the lumen of the inclusion as Ct
development progressed. ZNF23 is a repressor of a cell division
and a pro-apoptotic factor [27,28], and can interact with ACBD6.
The ER-bound acyl-CoA:lysophosphatidylcholine acyltransferase
1 (LPCAT1) enzyme was mobilized to the inclusion membrane
but not to the lumen. LPCAT1 catalyses the second step of the
Lands’ pathway and transfers long-chain acyl-CoAs to the sn-2
position of lysoPC to form PC [29,30].
We propose that sequestration of ZNF23 into the Ct inclusion is
another example of the bacterial-induced blockade mechanism of
host cell-death [20,31–36]. Our results establish that, in addition
to host-derived lipids and lipid bodies, lipid metabolic enzymes of
the host cell are also recruited into the inclusion. Furthermore,
lipids droplets that have been modified with membrane-bound
bacterial proteins have been identified in the inclusion lumen [18]
and could represent a vehicle to traffic ACSL3 and ACBD6 into
the lumen of the Ct vacuole. Mobilization of LPCAT1, also
identified in lipid droplets [37], to the inclusion membrane might
provide Ct with the ability to remodel PC into the lipid species it
requires.
Results
Long chain Acyl-CoA synthetase 3 (ACSL3) is recruited
into the Ct inclusion lumen
Among the different members of the ACSL family, member 3
and 6 have a strong preference for activation of long-chain fatty
acids toward synthesis of the glycerophospholipid phosphatidyl-
choline [38,39]. ACLS3 and ACSL6 are membrane proteins
associated with different organelles, such as the ER and Golgi
apparatus [24,25]. In HeLa cells infected with Ct strain D for 36
hr, ACLS3 protein was detected in the inclusion lumen (Figure 1,
panel A to C). The membrane surrounding the inclusion was
identified by staining for the bacterial protein IncA [11,40–42]
(Figure 1, panel A); the ACSL3 protein was detected with a
monoclonal antibody, which did not cross-react with Ct proteins
(Figure S1 and S2). However, the ACSL6 protein was not detected
in the inclusion lumen (Figure 1, panel D). Bacteria were detected
with an anti-LPS antibody. ACSL6 was produced in infected
HeLa cells but it did not localize in the Ct inclusion lumen. In cells
expressing a GFP-ACSL6 recombinant protein and infected with
Ct strain L2, the GFP signal was also not detected in the inclusion
(Figure S3). As shown in panel C of Figure 1, analysis of the
deconvolved Z stack merged image established that the ACSL3
protein was not associated with the membrane of the inclusion and
did not co-localize with the bacterium but was adjacent to it in the
lumen of the inclusion. Even at late stages of development and in
cells occupied by very large inclusions, only ACSL3 was located
inside the inclusion, while both ACLS3 and ACLS6 were present
in the cytosol.
Acyl-CoA:lysoPC acyltransferase 1 (LPCAT1) is mobilized
to the Ct inclusion membrane
Several acyl-Co:lysoPhosphatidyl acyltransferases (LPLATs)
have been identified in mammals but few enzymes are specific
for the acceptor species lysophosphatidylcholine (LPC) [43,44].
LPCAT1 is the re-acylating enzyme for PC in the ER and plasma
membranes [29,30], and also supports PC formation in the lipid
mono-layer, which surrounds the lipid droplet [37]. These lipid
bodies are formed from the outer lipid bi-layer of the ER [45]. In
HeLa cells expressing a GFP-LPCAT1 fusion protein and infected
with Ct strain D for 44 hr, LPCAT1 was not detected in the
inclusion but it was tightly associated to the membrane of the
inclusion (Figure 2, panel A and inset). Although the GFP signal
appeared to co-localize with the bacterial IncA protein in the
membrane surrounding the inclusion, the two signals were distinct
(Figure 2, inset and panel B). The pattern observed with the GFP-
recombinant protein in infected cells indicated that LPCAT1 is
located in, or at the proximity of the lipid-rich network
surrounding the inclusion [14,18]. This reticulate structure,
distinct from the ER and from the inclusion membrane, represents
a source of lipid-rich vesicles, such as lipid droplets, that are
engulfed in the inclusion.
Acyl-CoA binding protein 6 (ACBD6) is a nuclear protein
recruited into the Ct inclusion lumen
ACBD6 is a soluble acyl-CoA binding protein with preference
for long-chain un-saturated species abundant at the sn-2 position
of PC [26]. ABCD6 is highly expressed in the cytosol of progenitor
stem cells but it is also present in the nucleus [26]. We also
detected ABCD6 in the nucleus of HeLa cells (Figure 3, panel A
Figure 1. ACSL3 but not ACSL6 is recruited into the Ct
inclusion. HeLa cells were grown on coverslips and infected with Ct
strain D at a MOI of 1 in cell culture medium without antibiotics and
cycloheximide. Cells were fixed 36 hr post- infection. DNA was detected
with Hoechst 33258 dye (blue). Bacteria were detected with a rabbit
antibody against IncA, which was stained with an anti-rabbit antibody
labeled with AlexaFluorH488 revealing the inclusion membrane (green,
panels A to C) or with a mouse antibody against LPS, which was stained
with Cy
TM3-conjugated anti-mouse antibody (red, panel D). Long-chain
acyl-CoA synthetase 3, ACSL3, was detected with a mouse monoclonal
antibody (red, panel B and C) and ACSL6 protein was detected with a
rabbit antibody (green, panel D). The inclusion membrane of one
representative inclusion is indicated with an arrow in panel A and B.
Panel C displays a cropped portion of the image shown in panel B.
Insets in panel C and D display the orthogonal (z, x) and (z, y) views of
the deconvolved Z stack merged images. Images were taken with a
Zeiss LSM710 confocal microscope at 63x magnification. The bars in
panels and insets represent 10 mm. Note that the two insets of panel C
were slightly scaled up compare to the main image. Nuclei and
inclusion are indicated with N and Inc, respectively. ACSL3 protein was
detected inside the inclusion (panel B and C) and ACSL6 was not
(panel D).
doi:10.1371/journal.pone.0036843.g001
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F). During infection by Ct, the localization of ABCD6 was
dramatically altered and after 22 hr, no signal for the protein was
detected outside of the Ct inclusion. In HeLa cells infected with Ct
strain D, the protein signal disappeared from the cytosol and
nuclei, and was detected in the inclusion lumen (Figure 3, panel C
and D; Figure 5; Figure 6, panel A). This result was confirmed in
HEp-2 cells (Figure 3, panel G and H). The specificity of the
immunological detection of ACBD6 by the affinity-purified
antibody we used, was established by the detection of a single
band in protein extracts of HeLa cells (Figure 4, panel A), the
competition of the detection on fixed cells by an ACBD6 synthetic
peptide (Figure S4), and by the lack of cross-reactivity of the
antibody with total protein extracts of Ct strains D and L2
(Figure S1 and S2). Furthermore, analysis of deconvolved Z stack
merged images established that ABCD6 had been recruited into
the inclusion lumen since it did not co-localize with the bacterial
LPS signal (Figure 5, panel E).
Given the crucial role of Golgi-derived lipids in the expansion of
the inclusion, we investigated member 3 of the ACBD family. Like
ACBD6, ABCD3 is a soluble protein which binds acyl-CoAs, but
it is often associated with the Golgi apparatus by interaction with
the Golgi-membrane protein giantin [46]. In uninfected cells,
ACBD3 was detected at the periphery of the nuclei (Figure S5,
panel A). In infected cells, the signal intensity appeared weaker
and, in cells with large inclusions, which occupied most of the
cytosol, the protein was pushed aside (Figure S5, panel B). Thus,
fragmentation of the Golgi in the infected cells might affect
ACBD3 distribution [47,48], but it was not recruited into the
inclusion.
The Nuclear Pro-Apoptotic ZNF23 protein is recruited
into the Ct inclusion lumen
ZNF23 has been identified in a yeast two hybrid system with
ACBD6 as bait (P. Hauser, E. Soupene and F. Kuypers,
unpublished observations). ZNF23 is a KRAB_A containing zinc
finger protein controlling cell cycle progression, and can act as a
pro-apoptotic factor [27,28]. Regardless of the precise role of the
ZNF23 interaction with ACBD6, we decided to investigate its
putative role in Ct-infected cells. As other ZNF proteins, ZNF23 is
a nuclear protein and was detected in the nuclei of HeLa cells.
Unexpectedly, it was also detected in the cytosol (Figure 4, panel A
and Figure S6, panel A). The rabbit-raised antibody against
ZNF23 detected a band of the correct molecular mass in protein
extracts of human cells (Figure 4, panel A) and had no cross-
reactivity with Ct proteins (Figure S1 and S2). As observed with
ABCD6, ZNF23 disappeared from the cytosol and nucleus of cells
infected with Ct, and was only detected in the inclusion lumen
(Figure 6, panel B and Figure 7). These findings were confirmed in
cells infected by three different Ct strains (strain D, Figure 7E;
strain E, Figure 6B; strain L2, Figure 7 panel A to D), and with two
different anti-ZNF23 antibodies. ZNF23 was detected in the
inclusion with a rabbit antibody in cells infected with strain L2
(Figure 7, panel A to D) and strain E (Figure 6, panel B) and with
a mouse antibody in cells infected with strain D (Figure 7,
panel E). The mouse anti-ZNF23 antibody had no cross-reactivity
with Ct proteins (Figure S2). As observed for ACLS3 and ACBD6,
ZNF23 protein was detected in the lumen of the inclusion adjacent
to the bacteria (Figure 7, panel D and E).
Redistribution of ACBD6 and ZNF23 proteins in Ct-
infected cells
As described above, ACBD6 and ZNF23 are recruited into the
inclusion lumen, and are removed from the host compartment of
the infected cells. To determine when these two events occurred
and to assess if their disappearance was correlated to their
accumulation in the inclusion, we established the expression and
distribution profile of ACBD6 and ZNF23 in infected cells during
the developmental cycle of Ct. At the mRNA level, we could not
detect a significant change in expression of ABCD6 and ZNF23
from 0 to 36 hr post-infection for Ct strains D and L2 (Figure 8). In
addition, mRNA levels of ACBD3, ACSL3 and LPCAT1 also
remained fairly constant. As expected, expression of bacterial
development markers, such as incA, incG and ompA, were induced
several fold during growth of the bacteria. These results
Figure 2. LPCAT1 enzyme is tightly associated with the
inclusion membrane. HeLa cells were grown on coverslips in cell
culture medium without antibiotics and cycloheximide, and were
transfected with a DNA construct expressing a GFP protein fused to
acyl-CoA:lysophosphatidylcholine acyltransferase 1, LPCAT1. After
24 hr, cells were infected with Ct strain D at a MOI of 1 and were
fixed 44 hr post-infection. DNA was detected with the Hoechst dye
(blue) and the bacteria were detected with a rabbit antibody against
IncA revealing the inclusion membrane (red). A deconvolved Z stack
merged image with the GFP signal is shown in panel A. A cropped
section of the image is displayed in the inset. White arrowheads
indicate the position of the inclusion membrane. The tight association
of LPCAT1with the inclusion membrane and overlap of the IncA and
GFP signals, detected as yellow dots, can be observed in the inset.
Panel B shows traces of the intensity of the signal for DNA, IncA and
LPCAT1 (y axis) plotted in function of the distance (x axis) from area I to
II as indicated by a red arrow on panel A. GFP and IncA signals co-
localized in area I but not in area II. Images were taken with a Zeiss
LSM710 confocal microscope at 63x magnification. The bars in the
panel and the inset represent 10 and 1 mm, respectively.
doi:10.1371/journal.pone.0036843.g002
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of the expression of these human genes and that disappearance of
ACBD6 and ZNF23 was probably not the result of a transcrip-
tional shut down mechanism.
At the protein level, ABCD6 was located inside inclusions as
soon as these inclusions were detected at 12 hr (data not shown),
and it was still present in the cytosol and nuclei of infected cells for
the first 20 hours after infection (Figure 5, panel A to C).
However, two hours later, the ACBD6 signal had disappeared
from the host side of the inclusion membrane [Figure 5, panel C
(20 hr) and panel D (22 hr)]. The ACBD6 signal persisted in the
inclusions of Ct strain D late in development in HeLa cells
[Figure 6, panel A (24 hr) and Figure 3, panel D (36 hr)] and in
HEp-2 cells [Figure 3, panel H (36 hr) and Figure 9, panel B
(44 hr)]. Similarly, ZNF23 protein was recruited into the inclusion
as early in Ct development as ABCD6 was also detected (data not
shown). However, whereas ABCD6 persisted in the host
compartment for several more hours, ZNF23 signal disappeared
from the cytosol and nuclei of infected cells as soon as the protein
Figure 3. ACBD6 is mobilized into the Ct-inclusion lumen. Cells were grown on coverslips in cell culture medium without antibiotics and
cycloheximide. Near confluent cells were fixed in methanol (panel A, B, E and F) or were infected with Ct strain D at a MOI of 1 and fixed 36 hr post-
infection (panel C, D, G and H). Results for HeLa cells are shown in panel A to D and those obtained with HEp-2 cells are shown in panel E to H.
Human ABCD6 protein was detected with an affinity-purified polyclonal antibody (green). In infected cells, bacterial LPS was detected with a mouse
monoclonal antibody (red), and merged images with ACBD6 detection are shown in panel C and G. DNA was stained with the Hoechst dye (blue). In
un-infected cells, merged images with stained DNA are shown in panel B and F. In infected cells, merged images with stained DNA of the host and of
Ct cells are shown in panel D and H. In un-infected cells, ACBD6 was detected in the nucleus and the cytosol (panel A and E). In infected cells, ACBD6
protein was detected inside Ct inclusions (panel C and G) and not in the nuclei (panel D and H). Images were taken with a Zeiss LSM710 confocal
microscope at 63x magnification. The bars in panels represent 10 mm. Representative inclusions are indicated with white arrows and nuclei by a
capital N.
doi:10.1371/journal.pone.0036843.g003
Figure 4. Western immunological analysis of uninfected cells. HeLa cells were grown to near confluence in the same medium that was used
to perform the infection with Ct but cells were not infected. Panel A. Nuclear and cytosolic samples were obtained as described in the Method
section. As confirmed by coomassie blue staining (right panel), an equal amount of proteins (10 mg) of the nuclear (lane N) and cytosolic (lane C)
samples were loaded in each lane of a SDS-polyacrylamide 4–16 % gradient gels. After migration, the proteins were transferred on PVDF membranes
that were blotted with antibody against ACBD6, ZNF23 or ANKRD7. ANKRD7 is a known nuclear protein and was used as a control [66]. The molecular
mass standard (Precision Plus Protein Dual-Stained, Bio-Rad) is indicated on the right of the panels. A band of the predicted molecular mass of 32 kDa
and 64 kDa was detected for ABCD6 and ZNF23 respectively, in the cytosolic and nuclear samples. A major band of the expected size of 30 kDa
(asterisk) was detected for ANKRD7 in the nuclear extract. Panel B. ACSL3 protein was detected with the mouse anti-ACSL3 antibody in a total protein
extract of HeLa cells as described in panel A.
doi:10.1371/journal.pone.0036843.g004
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PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36843Figure 5. Redistribution of ACBD6 from the nucleus and cytosol into the inclusion lumen during Ct development. HeLa cells were
grown on coverslips and infected with Ct strain D at a MOI of 1 in cell culture medium without antibiotics and cycloheximide. After infection, cells
were fixed at the indicated time (panel A to D). ACBD6 (green), Ct LPS (red) and DNA (Hoechst dye, blue) were detected as described in legend of
Figure 3. For each time point, the staining obtained for ACDB6 and the merge image obtained for ACBD6, LPS and DNA are shown on the left and
right on each panel, respectively. Deconvolved Z stack images were analyzed with the Imaris Software package. Panel E shows the longitudinal
Surpass view (x, y, z) of the distribution of ACBD6, LPS and DNA in one infected-cell 24 hr post-infection. Note that ACBD6 was detected inside the
same space occupied by the bacteria in the inclusion, but did not co-localize with the LPS signal. Images were taken with a Zeiss LSM710 confocal
microscope at 63x magnification. The bars in panels represent 10 mm. Representative inclusions are indicated with white arrows and nuclei by a
capital N.
doi:10.1371/journal.pone.0036843.g005
Figure 6. Intensity distribution profiles of ACBD6 and ZNF23 in Ct infected cells. HeLa cells were grown on coverslips and infected in cell
culture medium without antibiotics and cycloheximide. Results obtained for ACBD6 in cells infected with Ct strain D 24 hr post-infection, and for
ZNF23 in cells infected with strain E 18 hr post-infection, are shown in panel A and B, respectively. The images were analyzed with ZEN 2010 software
(Zeiss LSM710). Traces of the intensity of the signal (y axis) were plotted in function of the distance (x axis) of the section of the cell indicated by a red
arrow (from left to right). Panel A shows the merged image of ACBD6 (green), LPS (red) and DNA (blue) in a cell with two inclusions. Panel B displays
the merged image of the signal for ZNF23 (green) and DNA (blue). Note that the Ct inclusion (Inc) can be detected with the Hoechst dye, which also
stained bacterial DNA.
doi:10.1371/journal.pone.0036843.g006
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Figure 6, panel B (18 hr)].
Discussion
The location of several host proteins is drastically altered during
Ct development. Remarkably, enzymes located in different
compartments of the host cell are recruited to the Ct inclusion.
These enzymes are mobilized to the inclusion membrane
(LPCAT1) or are translocated into the inclusion lumen (ACBD6,
ACSL3, ZNF23). Although, some host proteins have been
reported in the Ct inclusion membrane, none have consistently
been shown to localize in the inclusion lumen [5]. The membrane
protein CD59 was identified in the inclusion membrane facing the
lumen, but not within the lumen [49]. A second protein, CD63,
has been reported in the lumen of the Ct inclusion in HEp-2 cells
by one group [50,51]. CD63 was not detected in the inclusion
lumen formed by C. pneumoniae in HEp-2 cells [52], and was not
located with the bacterium in infected alveolar type II cells [53].
We were also not able to detect CD63 in the Ct inclusion lumen in
HEp-2 cells (Figure 9). We have no explanation for the apparent
detection of CD63 in Ct inclusions by Beatty et al. [50,51]. To our
knowledge, ACBD6, ACSL3, and ZNF23 represent the first
examples of human proteins mobilized into the Ct inclusion lumen.
Branched-chain phosphatidylcholine is the second most abun-
dant lipid of Ct membranes [22]. Straight-chain PC species
produced in the ER membrane of the host cells are translocated to
the membrane surrounding the inclusion. These host-PC species
are de-acylated to lysoPC moieties in the inclusion membrane,
probably by action of a host cPLA2, which is activated upon Ct
infection [32,54,55]. Ct-produced branched-chain fatty acids are
transferred onto host-lysoPC to generate the bacterial-PC species
that are incorporated into Ct membranes [16,17,22]. We
determined that human long-chain acyl-CoA synthetase member
3, ACSL3, is translocated into the inclusion lumen and that acyl-
CoA:lysophosphatidylcholine acyltransferase member 1,
LPCAT1, is recruited to the inclusion membrane. ACSL3 can
generate the activated-fatty acid species necessary for the re-
acylation reaction catalyzed by LPCAT1. ACSL3 and LPCAT1
specifically act toward synthesis of PC [37,39,56] and, therefore,
likely also of the Ct-PC species.
We also found that the acyl-CoA binding protein ACBD6 was
recruited into the inclusion lumen. Its role in PC metabolism is
supported by its binding preference for long-chain fatty acids
species abundant at the sn-2 position of PC [26]. The drug triacsin
C, which inhibits some of the host acyl-CoA synthetase enzymes,
has been shown to severely impair the growth and development of
Ct [18]. Among the different members of the ACSL family,
ACSL3 is the form most sensitive to triacsin C treatment, which
could, in part, explain the noted effect on Ct growth and
development. ACSL6, which was not mobilized into the inclusion,
is not sensitive to the drug (reviewed in [25]).
ACSL3 and LPCAT1 enzymes also have the unusual property
among membrane proteins to bind the lipid mono-layer
surrounding lipid droplets [37,39,56]. In infected human cells,
Ct proteins (Lda and IncA) are also associated with lipid droplets
Figure 7. The nuclear ZNF23 protein is mobilized into the lumen of the Ct inclusion. HeLa cells were grown on coverslips and infected in
cell culture medium without antibiotics and cycloheximide. Cells were infected at a MOI of 1 with Ct strain L2 (panel A to D) and with D (panel E) and
were fixed 36 hr post-infection. DNA was detected with the Hoechst dye (blue). In cells infected with L2, the bacteria were detected with a mouse
antibody against LPS (red, panel B and D) and the ZNF23 protein was detected with a rabbit antibody (green, panel C and D). Z stack images were
deconvolved and single channel Surpass 3D view of a representative infected cell is shown in panel A to C. Cropped longitudinal view of the Surpass
(x, y, z) view of the merged image is shown in panel D. In Panel E, the inclusion membrane was detected with a rabbit antibody against the bacterial
IncA protein (green) and the ZNF23 protein was detected with a mouse antibody (red), and the merged image with Hoechst staining is shown.
Images were taken with a Zeiss LSM710 confocal microscope at 63x magnification. The bars in the panels represent 10 mm. Nuclei and inclusion are
indicated with N and Inc, respectively.
doi:10.1371/journal.pone.0036843.g007
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bacteria and they appeared to be closely associated with the RBs
inside the inclusion [4,14,18]. These lipid bodies can cross into the
inclusion, without being absorbed by the phospholipid bilayer of
the membrane [18]. Together with lipids that they contain, the
host enzymes, in particular ACSL3, that are associated with these
lipid bodies could then translocate into the inclusion lumen. In
that context, these lipid bodies could represent a major support
mechanism for the lipid metabolism of Ct.
ZNF23 is a member of the C2H2-type sub-family of the large
zinc finger family. ZNF23 contains 17 repeats of the Cys2-His2
motif and belongs to the class of ZF proteins with Kru ¨ppel-
associated box (KRAB) type A [27,28]. These nuclear proteins are
transcriptional factors usually responsible for repression by
recruitment of other protein(s). ZNF23 is a pro-apoptotic factor
that acts as a repressor of cell division [27,28]. The role of ZNF23
in lipid metabolism is unknown but preliminary results indicate
that it can interact with ACBD6 protein in a yeast two-hybrid
system (P. Hauser, E. Soupene and F. Kuypers, unpublished
observations). ACBD6 and ZNF23 are located in the cytosol and
nucleus of cells. In cells infected by Ct for more than 20 hr, we
found that these two proteins were no longer present in host cell
nuclei or cytoplasm but were located in the inclusion lumen.
However, the depletion observed for ACBD6 and ZNF23 was not
detected for ACSL3, which was also recruited into the inclusion
lumen, and there were no detectable changes in mRNA levels for
any of the enzymes we tested. Thus, ACBD6 and ZNF23 appear
to be the target of an, as yet, unidentified removal mechanism that
takes place when inclusions have started to fuse and enlarge. This
mechanism(s) did not appear to affect the intracellular location of
any of the other proteins we studied (ACSL3, ACSL6, ACBD3,
CD63, LPCAT1). Sequestration into the inclusion would protect
ACBD6 and ZNF23 from degradation, which likely occurs in the
cytosol of the host-infected cell.
Human infected cells are protected against stimuli inducing the
mitochondrion-dependent cell death program [4,31,33,35]. Ct-
infected cells activate anti-apoptotic signaling pathways, such as
the Raf/MEK/ERK survival pathway, recruit host death
receptors to the inclusion membrane, and several pro-apoptotic
host proteins are targeted for degradation by Ct secreted proteases
[32–34,36,57–59]. ZNF23, which we discovered was also recruit-
ed into the inclusion lumen, has been shown to down-regulate the
level of the Bcl-XL protein in some cancer cells [27]. Bcl-XL is a
member of the BCL-2 family. It acts against the pro-apoptotic
function of BAX-BAK complex and prevents cytochrome c-
released (review in [4,31,60]). Activation of BAX-BAK, by BH3-
containing proteins such as BAD, is prevented in Ct-infected cells
[36]. Early in the developmental process, Ct CPAF protease is
secreted into the host cytosol where it targets BAD and other
human BH3-proteins for degradation [33,34,57,61]. Moreover,
the phosphorylated form of BAD is sequestered away from the
mitochondria membrane by its association with the host protein
14-3-3ß at the inclusion membrane. [36]. Protein 14-3-3ß is
recruited by means of its association with the phosphorylated form
of the bacterial IncG protein [62]. IncG, produced by Ct inside the
inclusion, is imported to the membrane of the inclusion where it is
phosphorylated by a host tyrosine kinase [42,62]. Although, not
completely understood, a regulated and coordinated mechanism is
Figure 8. Expression of host proteins recruited to the inclusion is not altered in Ct infected cells. HeLa cells were grown in 24-well plates
in cell culture medium without antibiotics and cycloheximide. Cells were infected at a MOI of 5 with Ct strain D (panel A. middle graph and panel B)
and with L2 (panel A, right graph and panel C). Some cells were not infected (panel A, left graph). At the indicated time, total RNAs were isolated and
cDNAs were synthesized with random primers. qPCR analysis was performed as described in the Method section. Expression levels of the human
genes ACBD3, ACBD6, ACSL3, LPCAT1 and ZNF23 (panel A) were normalized to levels of GAPDH gene. In cells infected with Ct D (panel B) or with Ct L2
(panel C), Ct genes incA, incG and ompA were normalized to expression levels of the euo gene. For each gene, expression level ratio obtained at time
point 0 hr was arbitrary set at a value of 1 and all other ratios were calculated relative to it. Note the difference of the x axis scale of the 3 plots in
panel A compare to the graph in panel B and C.
doi:10.1371/journal.pone.0036843.g008
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death of the host cells. Our findings suggest that in addition to the
sequestration and inactivation of the ‘pro-pro-apoptotic’ BAD
protein, the complete translocation of ZNF23 into the inclusion
lumen, perhaps through its interaction with ACBD6 in complex
with lipid bodies engulfed into the inclusion, would protect the
infected cells from the ‘anti-anti-pro-apoptotic’ effect of ZNF23.
Our results provide further evidence that via protection inside
the parasitophorous vacuole, Ct can disrupt host cellular pathways,
such as lipid body trafficking and initiation of programmed cell-
death, by secretion of bacterial proteins and by mobilization of
specific host enzymes into the inclusion lumen.
Materials and Methods
Cell culture and infection
HeLa229 cells [63], obtained from ATCC (CCL-2.1) were
grown in minimal essential medium with glutamine (MEM alpha,
Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum
(UCSF Cell Culture Facility, San Francisco, CA). HEp-2 cells
[50,51], obtained from ATCC (CCL-23) were maintained in low-
dextrose MEM with glutamine (DMEM, Invitrogen). For micros-
copy studies, cells were grown, transfected and infected on 12-mm
round coverslips (Electron Microscopy Sciences, Inc., Hatfield,
PA) in 24-well plates (E&K Scientific, Santa Clara, CA). Cells
grown to 70% confluence were infected with Ct strains D, E or L2
at a multiplicity of infection (MOI) of 1 to 5, as indicated in the
legend of the figures and as previously described [63]. After 1 hr,
the inocula were aspirated and fresh growth medium supplement-
ed with 40 mM gentamicin (MP Biomedicals, Solon, OH) was
added to the infected cells. At the indicated times, medium was
aspirated, cells were washed twice with PBS and were fixed with
ice-cold methanol for 10 minutes. After aspiration cells were
washed twice with PBS and kept at 4uC until use.
Immunochemical detection
Fixed cells were incubated in a blocking solution (PBS with
0.1% Tween-20 and 5% goat serum) over-night at 4uC.
Incubations with primary antibodies were performed in 400 ml
PBS with 0.1% Tween-20 and 1% BSA, for 3 to 4 hr at room
temperature on a rocking platform. To detect bacteria, a Ct-
specific lipopolysaccharide (LPS) monoclonal antibody (MAb)
(Virostat, Portland, ME) at a 1/1,000 dilution and a Ct-specific
IncA polyclonal antibody (generous gift from Ted Hackstadt to
DD) at a 1/200 dilution were used. Antibodies against human
proteins included a mouse monoclonal against ACSL3 (clone H9,
Santa Cruz Biotechnology, Inc.), a MAb against ACBD3 (clone
2H2, Abnova, Jhongli, Taiwan), a MAb against CD63 (clone MX-
49.129.5, Santa Cruz Biotechnology, Inc. Santa Cruz, CA), a
mouse polyclonal against ZNF23 (ab68252, Abcam Inc., Cam-
bridge, UK), an affinity-isolated rabbit polyclonal against ZNF23
(SAB4503115, Sigma-Aldrich, St Louis, MI), and affinity-purified
custom-made rabbit polyclonal against ACBD6 [26] and ACSL6
[64]. All antibodies were used at a dilution of 1/500. Conjugated
secondary antibodies were incubated protected from light for 1 to
2 hr under the same condition. Cells were washed three times in
PBS, and DNA was revealed by staining with 200 ml of 0.5 mg/ml
Hoechst 33258 dye (Invitrogen, Carlsbad, CA) in PBS for 10 min.
Dye was removed by two washes with PBS.
Microscope image acquisition
Coverslips were mounted on glass slides embedded in FluorSave
Reagent (EMD Biosciences, Darmstadt, Germany). Microscopy
analysis was performed with a Zeiss LSM 710 confocal inverted
microscope at room temperature. Magnifications and scale bars
are indicated in the legend of each figure. Image processing,
deconvolution, 3D reconstruction and colocalization analysis were
performed with Huygens Essential and Bitplane Imaris Suite
package of Scientific Volume Imaging (Hilversum, The Nether-
lands).
Proteins sample preparation and cell fractionation
For isolation of nuclei, HeLa cells were grown to near
confluence in a T75 flask and harvested by trypsin treatment.
The cell pellet was kept on ice and was washed once in ice-cold
hypotonic buffer containing 10 mM HEPES pH 7.9, 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM DTT and 0.2 mM PMSF. Cells
were suspended in 5 volumes (< 1 ml) of the same buffer and
allowed to swell for 20 min on ice. The cells were transferred in a
Dounce homogenizer and homogenized by 10 to 15 strokes.
Complete lysis of the cells was determined by light microscopy.
The broken cell suspension was centrifuged at 6,000 rpm for
5 min. The supernatant was separated from the pellet, represent-
ing the crude cytosolic fraction. The pellet was gently washed with
hypotonic buffer, and the presence of intact nuclei was verified by
staining with trypan blue observed under light microscopy. The
nuclei pellet was suspended in a small volume of buffer (< 100 ml).
Protein concentration in the supernatant and nuclei was deter-
mined with the colorimetric RC-DC Protein assay (Bio-Rad,
Figure 9. CD63 is not localized in the Ct inclusion of infected
HEp-2 cells. HEp-2 cells were grown on coverslips and infected with Ct
strain D at a MOI of 1 in cell culture medium without antibiotics and
cycloheximide. Cells were fixed 44 hr post-infection. In panel A and B,
CD63 protein was detected with a mouse monoclonal antibody (red). In
panel A, the inclusion membrane was stained with a rabbit antibody
against IncA (green), DNA was detected with the Hoechst dye (blue),
and the merged image is shown. In panel B, the bacteria were only
detected by Hoechst DNA staining and ACBD6 was detected with a
rabbit antibody (green), and the merged image is shown. Signal
distribution of the orthogonal (z, x) slice of deconvolved Z stack images,
indicated by the arrow on the respective merged image, are displayed
in the inset of each panels. Images were taken with a Zeiss LSM710
confocal microscope at 43x magnification. The bars in panels represent
10 mm. Nuclei and inclusion are indicated with N and Inc, respectively.
Note that CD63 signal was not detected in the inclusions (panel A) and
did not co-localize with ABCD6 protein, which was detected inside the
inclusions (panel B).
doi:10.1371/journal.pone.0036843.g009
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were lysed and dissolved by boiling in the SDS-PAGE loading
buffer for 5 min. Proteins samples were separated under denatur-
ing condition on 4–16% gradient polyacrylamide gel (Bio-Rad).
Protein samples of EBs were prepared by boiling 50 ml of a frozen
stock of 5x10
8 per ml of purified EBs of Ct strain D or L2 with
50 ml of SDS-PAGE loading buffer 2x for 5 min and by vigorous
vortexing. Samples were centrifuged for 30 s at full-speed
(14,000 g) to remove insoluble debris, and 10 ml were loaded on
a 4–16% gradient polyacrylamide gel (Bio-Rad). Following
electrophoresis, proteins were transferred on PVDF membrane.
Western blot immunodetection
PVDF membrane were blocked overnight at 4uC in TBS with
0.05% Tween-20 and 5 % non-fat milk. Primary antibodies
(mouse anti-ACSL3, mouse anti-HSP60, rabbit anti-ACBD6,
rabbit anti-ANKRD7, and rabbit anti-ZNF23) were diluted 1/
2,500 in TBS with 0.05% Tween-20 and 1 % milk and incubated
2 to 4 hr at room temperature on a rocking platform. Peroxidase-
conjugated secondary antibodies (goat anti-mouse and goat anti-
rabbit) (Bio-Rad), diluted 1/1,000 in TBS with 0.05% Tween-20
and 1 % milk, were incubated 1 to 2 hr under the same condition.
Detection was performed with SuperSignal West Pico Chemilu-
minescent kit (Thermo Fisher Scientific Inc., Rockford, IL).
DNA manipulation and transfection
Full-length LPCAT1 cDNA [30] and ACSL6 cDNA [64,65]
were cloned into the pAcGFP1 vector (Clontech Laboratories,
Mountain View, CA) to generate a fusion of the GFP protein to
their amino-terminal extremity. Briefly, PCR cloning was
performed with High-Fidelity Expand Taq DNA polymerase
(Roche Applied Science, Indianapolis, IN) using the plasmid
pFK182 as template, and the following primer pair (59-
CTAGAGCTCAGACACAGGAGATCCTGAGGATAC-39;5 9-
CTAGGATCCTCACATGGAGATTGAGTAAAGCTCTTC-
39).
The PCR product was cloned with Zero-Blunt PCR cloning kit
(Invitrogen) and was sequenced to comfirm the absence of base
error. The vector was cloned in-frame at the EcoICRI/BamHI
restriction sites of pAcGFP1 to yield plasmid pFK338. A similar
cloning strategy was used for LPCAT1. The PCR product was
obtained with template pFK189 and the following primer pair (59-
TTGATATCCTAGCGCCGCCCCCTCCTCC-39;5 9-ATG-
GATCCCTAGTCCGCTTTCTTACAAGAATTC-39), to yield
plasmid pFK642. DNA transfections of HeLa cells grown on
coverslips in 24-well plates were performed with NanoJuice
transfection reagent (EMD Bioscience, Darmstadt, Germany)
using 0.8 mg of circular plasmid DNA, a DNA to Core ratio of
1 and, a DNA to Booster ratio of 4. Cells were fixed or infected
with strains D or L2 after 24 hr.
Reverse transcription and real-time PCR
For gene expression analysis, HeLa cells were infected in
duplicate in 48-well plates at an MOI of 5. Total RNA was
extracted at 0, 2, 6, 12, 24 and 36 hr postinfection using RNeasy
MINI kit (Qiagen, Valencia, CA) following the manufacturer’s
instructions with an on-column DNase treatment (Qiagen,
Valencia, CA). Following elution off the column, trace amounts
of DNA in the RNA preparation was further removed by
treatment with TurboDNase (Ambion, Austin, TX). DNA-free
RNAs were extracted with phenol-chloroform and concentrated
by ethanol precipitation. No-RT control PCR reactions were
performed with iTAQ SYBR GreenH Supermix (Bio-Rad,
Hercules, CA) using a human ACTB primer pair or a Ct ompA
primer pair on an ABI7000 instrument. RNA samples were
considered DNA-free when no signal was detected at C-threshold
values less than 35 for a 40 cycle amplification program.
Bacterial gene expression was determined with ompA, incA, incG
and euo gene-specific PrimeTime qPCR probes conjugated with
FAM fluorescent dye and with Iowa BlackHFQ and Internal ZEN
quenchers (IDT DNA Technologies, Coralville, IO). Sequence of
primer (fwd/rev) and probe sets were as follow: ompA [(59-TTC
TAT GGG AAG GTT TCG GC-39/59-CAC GGT CGA AAA
CAA AGT CAC-93) and probe 59-/56-FAM/AGA TCC TTG/
ZEN/CGA TCC TTG CAC CA/3IABkFQ/-39]; incA [(59-TTT
TAG CTC TTT TGG GAC ATC TTG-39/59-TGC TAA TGA
GGT AAT GAA TAG GGC-39) and probe 59-/56-FAM/TGG
CTT TCT/ZEN/GAT CGC TCC ACA CA/3IABkFQ/-39];
incG [(59-ACG AAA TGC TTA CAA ACG GC-39/59-AGT GCC
ACT AAA CAG TAC CG-39) and probe 59-/56-FAM/TTC
CTG AAG/ZEN/CAA ACA CCG CAA ACA A/3IABkFQ/-
39]; euo [(59-TTA TTC CGT GGG ACA AGT GG-39/59-TGA
ATG ACC CAA GCA GAT CC-39) and probe 59-/56-FAM/
ATT GGT GCT/ZEN/ATG AAA GGA GAG CGT CG/
3IABkFQ/-39]. cDNA was generated from 2 mg of total RNA
using random primers and AffinityScript QPCR cDNA Synthesis
kit (Agilent Technologies Inc., Santa Clara, CA) in a 20 ml
reaction, according to manufacturer’s instructions. Real-time PCR
reactions were performed with 0.25 ml of cDNA per reaction and
500 nM of gene-specific qPCR probe, using Brilliant II QPCR
Master Mix with ROX (Agilent Technologies Inc., Santa Clara,
CA). Quadruplicates reactions were performed in 5 ml volume in
384-well plate format and were run on a ABI7900HT instrument
(Applied Biosystems, Foster City, CA).
Human gene expression was determined with ACBD3, ACBD6,
ACSL3, LPCAT1, ZNF23 and GAPDH gene-specific RT
2 qPCR
Primers (Qiagen, Valencia, CA). Real-time PCR reactions were
performed with 0.5 ml of cDNA per reaction and 400 nM gene-
specific RT
2 qPCR Primer, using iTAQ SYBR GreenH Supermix
with ROX (Bio-Rad, Hercules, CA). Reactions were performed in
triplicate in 13 ml volume in 96-well plate format and were run on
a ABI7000 instrument (Applied Biosystems, Foster City, CA).
Expression levels of Ct incA, incG and ompA genes were
normalized to the values obtained for the euo gene [42]. Expression
of human ACBD3, ACBD6, ACSL3, LPCAT1 and ZNF23 genes
were normalized to the values obtained for the GAPDH gene. For
each gene, normalized value obtained at time 0 was used as
reference. The DDCt method was used to determine the
expression level values of bacterial and human genes in infected
cells from 2 to 36 hr relative to 0 hr.
Supporting Information
Figure S1 Lack of anti-human protein antibody reactiv-
ity against Ct proteins analyzed by Western blot. Proteins
were separated under denaturing condition in presence of SDS,
and result of a coomassie blue staining is shown on the right.
Following electrophoresis, the proteins were transferred onto a
PVDF membrane. After transfer, the membrane was cut as
indicated on panel A and B. After blocking, each portion was
incubated with primary antibodies against the human proteins
ACBD6, ACSL3 or ZNF23. Ct protein HSP60 and host GAPDH
were used as controls. Detection was performed with SuperSignal
West Pico Chemiluminescent kit (Thermo Scientific). As indicated,
the portions of the membranes were exposed to the same films for
the same period of time. Panel A. Protein extracts of Ct strain D
and L2, prepared as described in the Method section, were boiled
in presence of SDS-PAGE loading buffer and approximatively
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Panel B. Mouse Mc Coy cells were infected with Ct D at a MOI of
1. Proteins from uninfected cells (-) and from cells infected for
24 hrs (+) were isolated and analyzed as described in panel A. As
shown, even under long exposure conditions, which resulted in a
very strong signal for the bacterial protein HSP60 and host
GAPDH no signal was detected in EBs and in Ct-infected McCoy
cells with the antibodies used against the human proteins.
(TIF)
Figure S2 Lack of anti-human protein antibody reactiv-
ity against Ct proteins as shown by immuno-histochem-
istry. Mouse McCoy cells were grown on coverslips in cell culture
medium without antibiotics and cycloheximide. At near conflu-
ence, cells were fixed (uninfected, left panels) or were infected with
Ct strain D at a MOI of 1 and were fixed 36 hr post-infection.
DNA was stained with the Hoechst 33258 dye (blue). Human
ACSL3 and ZNF23 were detected with mouse antibody stained
with a Cy
TM3-conjugated anti-mouse antibody (red) and bacterial
MOMP protein was detected with a rabbit antibody stained with
an AlexaFluorH488-conjugated anti-rabbit antibody (green).
Human ACBD6 and ZNF23 were detected with rabbit antibody
stained with an AlexaFluorH488-conjugated anti-rabbit antibody
(green) and bacterial LPS was detected with a mouse monoclonal
antibody stained with Cy
TM3-conjugated anti-mouse antibody
(red). Merged images are shown on the right panel of each row.
Images were taken with a Zeiss LSM710 confocal microscope at
40x magnification. The bars in panels represent 10 mm. Note that
in each row, a cropped snap shot of panel 2 is shown in panel 3, 4,
5, and 6. None of the anti-human antibody reacted with antigen in
the inclusion.
(TIF)
Figure S3 GFP-ACSL6 protein is not detected in Ct
inclusion. HeLa cells were grown on coverslips and were
transfected with a DNA construct expressing a GFP-ACSL6
fusion. After 24 hr, cells were infected in cell culture medium
without antibiotics and cycloheximide with Ct strain L2 at a MOI
of 1. Cells were fixed 24 hr post-infection. Bacterial LPS was
detected with a mouse monoclonal antibody, which was stained
with Cy
TM3-conjugated anti-mouse antibody (red), DNA was
stained with the Hoechst 33258 dye (blue) and merged images
with LPS signal (middle panel) and with LPS and GFP (right
panel) are shown. Images were taken with a Zeiss LSM710
confocal microscope at 63x magnification. The bar in the panel
represents 10 mm. Nuclei and inclusion are indicated with N and
Inc, respectively. ACSL6 is not recruited to the inclusion.
(TIF)
Figure S4 Competition of the immuno-histological
detection of ACBD6 by an ACBD6 peptide. HeLa cells
grown on coverslips in cell culture medium without antibiotics and
cycloheximide. At near confluence, some cells were fixed (images
shown) or were infected with Ct strain D at a MOI of 1 and fixed
36 hr post-infection (data presented in the inset). Affinity-purified
polyclonal anti-ACBD6 antibody was stained with an anti-rabbit
antibody labeled with AlexaFluorH488 (green). DNA was stained
with Hoechst 33258 dye (blue). For peptide treatment, 40 nmole
of the synthetic antigenic ACBD6 peptide was added during the
incubation with the primary antibody (anti-ACBD6 antibody).
Images were taken with a Zeiss LSM710 confocal microscope at
40x magnification using the same exposure settings for the un-
treated and treated coverslips. The bars in panels represent 10 mm.
Note that whereas Hoechst dye’s staining was of similar signal
intensity in un-treated and treated samples, signal intensity for
ACBD6 of the treated cells was visibly weaker in presence of the
peptide. The same treatment was performed on infected cells, and
the result of a semi-quantitative analysis is shown in the inset. To
estimate the decrease in signal intensity observed for staining of
ACBD6 in Ct inclusions in presence of the peptide, signal intensity
in the nuclei of the infected cells was determined, and it was used
to normalize the intensity values obtained in the inclusion. The
signal intensity of at least 15 different cells per condition was
determined. The signal intensity of Hoechst staining across the
nucleus was expressed relative to the length of the section in mm
and the assumption was made that this value was not affected by
the presence or absence of the ACBD6 peptide. The signal
intensities of ACBD6 staining per mm were determined across the
inclusion of the same cells. The ratio of these values obtained for
the untreated coverslip was arbitrary set at 1 and the ratio of the
values for the treated sample was calculated from it.
(TIF)
Figure S5 Golgi-associated ACBD3 is not recruited to
the Ct inclusion. HeLa cells grown on coverslips in cell culture
medium without antibiotics and cycloheximide. At near conflu-
ence, some cells were fixed (panel A) or were infected with Ct
strain L2 at a MOI of 1 and were fixed 36 hr post-infection
(panel B). Human ABCD3 protein was detected with a mouse
monoclonal antibody stained with a Cy
TM3-conjugated anti-
mouse antibody (red). In infected cells, bacterial MOMP protein
was detected with a rabbit antibody, which was stained with an
AlexaFluorH488-conjugated anti-rabbit antibody (green). DNA
was stained with the Hoechst 33258 dye (blue). Merged images are
shown. Images were taken with a Zeiss LSM710 confocal
microscope at 40x magnification. The bars in panels represent
10 mm. On panel B, representative inclusions and nuclei are
indicated with Inc and capital N, respectively. ACBD3 protein is
not recruited into the inclusion.
(TIF)
Figure S6 Redistribution of ZNF23 from the nucleus
and cytosol into the inclusion lumen during Ct develop-
ment. HeLa cells were grown on coverslips in cell culture
medium without antibiotics and cycloheximide. At near conflu-
ence, some cells were fixed (panel A, 0 hr) or were infected with Ct
strain E at a MOI of 1 and were fixed 16 hr post-infection
(panel B). Human ZNF23 protein was detected with a rabbit
antibody stained with an AlexaFluorH488-conjugated anti-rabbit
antibody (green). DNA was stained with the Hoechst 33258 dye
(blue). Images were taken with a Zeiss LSM710 confocal
microscope at a magnification of 40x in panel A and of 63x in
panel B. The bars in the panels represent 20 mm. Note that the
bacteria were only detected by staining their DNA with the
Hoechst dye. The results obtained for staining of ZNF23 and the
merged image obtained with stained DNA are shown. On
panel B, an inclusion (Inc) and a nucleus are indicated by an
arrow and with a capital N, respectively. In un-infected cells
(panel A), ZNF23 is located in the cytosol and nucleus. In infected
cells, ZNF23 has been recruited into the inclusions and is no
longer detected in the host cell.
(TIF)
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